500 patients join hunt for genetic clues in brain vessel disease
NCT ID NCT05473637
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is following 500 people with cerebral small vessel disease (CSVD) to see how their genes affect their brain scans, symptoms, and health over time. Participants get genetic testing and MRI scans at the start and again after 1-2 years. The goal is to better understand the differences between genetic and non-genetic forms of CSVD, which could improve diagnosis and future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and manage brain small vessel disease based on genetic types.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct benefits for participants, and results may take years to apply in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CADASIL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Neurology, National Taiwan University Hospital
RECRUITINGTaipei, 100, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Can brain scans reveal hidden language struggles after stroke?
- Can early enzyme therapy save kidneys in fabry disease?
- Can continued lucerastat access help fabry patients?
- A closer look: could hysteroscopy guide better repair of cesarean scar defects?
- Can lifestyle choices after a stroke extend life and prevent a second one?